A contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Services offered by CMOs include, but are not limited to: pre-formulation, formulation development, stability studies, method development, pre-clinical and Phase I clinical trial materials, late-stage clinical trial materials, formal stability, scale-up, registration batches and commercial production. CMOs are contract manufacturers, but they can also be more than that because of the development aspect.

MHRA Approved Upperton New Facilities

Spray drying specialist has invested in building enhancements and in the expansion of its processing and analytical capabilities The UK Medicines and Healthcare products Regulatory Agency (MHRA) ha...

Fujifilm Invests $90m to Expand its FDB

Fujifilm Corporation announced plans to invest approximately $90 million to expand its bio contract development and manufacturing organization (CDMO) business— Fujifilm Diosynth Biotechnologies (FDB)....

TOBIO Closed $45m Series A Financing to Advance Phase II CDMO

Thousand Oaks Biopharmaceuticals, an integrated global chemistry, manufacturing and controls (CMC) organization including GMP cell culture media and biomanufacturing capabilities, has closed a $45 mil...

AGC boosts its biopharmaceutical production capacity

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

Rentschler Biopharma buys US manufacturing facility from Shire

Rentschler Biopharma, a leading contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire.

Swedish Alliance for ADHD Treatment

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treat...

Spanish CDMO ready to meet EU serialisation regulations

Company now able to serialise commercial batches manufactured by them for clients; it can also offer standalone serialisation services as an outsourcing partner. CDMO Idifarma has confirmed it is r...

AGC buys API manufacturer from Boehringer Ingelheim

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals.

Voyager Therapeutics entered into collaboration with Brammer Bio and Fujifilm

Voyager Therapeutics announced that it has entered into collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to expand manufacturing capabilities.

Cobra Biologics receives a research grant from Innovate UK

Cobra Biologics, an international contract development and manufacturing organization with a focus on advanced therapy medicinal products, has won a £1.5 million shared grant from Innovate UK.

Rentschler Fill Solutions launched a fill and finish facility in Austria

pharma vial
Rentschler Fill Solutions GmbH, a contract development and manufacturing organization and expert in aseptic fill and finish services, officially inaugurated its new facility in Rankweil (Austria).

Piramal Pharma to open its new cGMP kilo lab suite in India

Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization, announced the completion of its new cGMP kilo lab suite at its API site in Ennore (Chennai, India).

Cambrex Corporation buys Avista Pharma Solutions

Cambrex, the leading manufacturer of small molecule innovator and generic APIs and finished dosage forms, announced it has entered into a definitive agreement to acquire Avista Pharma Solutions.

Idifarma and Palobiofarma start a new drug development project

Idifarma (Spain), a contract development and manufacturing organization (CDMO), has begun its seventh project with biotechnology company, Palobiofarma (Spain).

Iovance and MaSTherCell entered into manufacturing services agreement

MaSTherCell will manufacture TIL for Iovance’s European late-stage clinical trials in its commercial-ready cGMP manufacturing suites.

Hovione plans to further expand its production capacity

Hovione announces plan to increase production capacity in oral dosage forms. New commercial scale equipment for blending, tableting and coating will complement existing small scale equipment.